GlassScriptPhysician profile
Mary P Trainor
NPI 1497732770
$379.39
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $113.10 | 2019 | |
| Pfizer INC. | $54.94 | 2019 | |
| Daiichi Sankyo INC. | $45.70 | 2019 | |
| Merck Sharp & Dohme LLC | $30.92 | 2019 | |
| Covidien LP | $27.76 | 2019 | |
| Kci USA, INC. | $20.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.49 | 2019 | |
| Tactile Systems Technology INC | $14.05 | 2019 | |
| Minerva Surgical, INC | $14.04 | 2019 | |
| Hologic Sales and Service, LLC | $13.34 | 2019 | |
| Exeltis, USA INC. | $11.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Trainor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.